INOInovio Pharmaceuticals, Inc.
1.180USD-9.23%Mkt Cap: 122.01M $P/E: —3d ago
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), c…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap122.01M $
Enterprise Value96.44M $
Revenue (TTM)0 $
Gross Profit-48.49M $
Net Income (TTM)-84.95M $
Revenue/Share0.0000 USD
Last Price1.180 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees112
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45773H2013
Valuation
P/E (Trailing)—
P/E (Forward)-2.75
PEG—
EV/EBITDA-1.24
EV/Revenue—
P/SInfinity
P/B13.91
EPS (TTM)-0.97
EPS (Forward)-0.44
52W Range
0.566625% of range2.980
52W High2.980 USD
52W Low0.5666 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-130000.00%
ROE-352.53%
ROA-114.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-88.63M $
CapEx (TTM)285.70K $
FCF Margin—
FCF Yield-27.75%
Net Debt-28.67M $
Net Debt/EBITDA0.37
Balance Sheet
Debt/Equity0.39
Current Ratio1.00
Quick Ratio0.92
Book Value/Sh0.0870 USD
Cash/Share0.3550 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateJan 25, 2024
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.167 USD
Upside (mean)+168.4%
Target Range2.500 USD – 4.000 USD
$2.500+168.4% to mean$4.000
# Analysts3
Ownership
Shares Out.103.40M
Float96.22M
Insiders0.33%
Institutions46.01%
Short Interest
Short Ratio4.7d
Short % Float17.22%
Short % Out.15.53%
Shares Short16.04M
Short (prev mo.)15.04M
Technical
SMA 501.034 (+14.1%)
SMA 2001.476 (-20.1%)
Beta1.51
S&P 52W Chg18.16%
Avg Vol (30d)4.62M
Avg Vol (10d)6.13M
Technical Indicators
RSI (14)62.2
MACD0.0213
MACD Signal-0.0475
MACD Hist.+0.0688
BB Upper1.295 USD
BB Middle0.8815 USD
BB Lower0.4677 USD
BB Width93.88%
ATR (14)0.1011 USD
Vol Ratio (20d)0.81x